Other potential DILI biomarkers under investigation include high-mobility group protein B1 (HMGB-1), a nuclear protein released during necrosis, and the ratio of cleaved to full-length cytokeratin [72]
The question of building muscle on GLP-1 is important because the caloric deficit created by these medications can work against muscle growth
This level of support helps ensure consistency, build confidence in progress, and reduce the common pitfalls that can arise when navigating GLP-1 treatment without professional guidance
Dosing flexibility differs between medications, with tirzepatide offering more granular titration options through its injection format
The maintenance phase requires as much intentional engagement with nutrition, activity, sleep, and medication adherence as the weight loss phase did. Part of the reason is biological